Lastly, in agreement with our data showing STING loss is associated with resistance to DNA damage, analysis of a cohort of patients with head and neck squamous cell carcinoma shows that low tumor STING expression is associated with worse oncologic outcomes. Here, STING1 is linked to head and neck squamous cell carcinoma.